Eqc Private Markets Sac Fund Ltd-eqc Biotech Sely Ii Fund` - Net Worth and Insider Trading

Eqc Private Markets Sac Fund Ltd-eqc Biotech Sely Ii Fund` Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eqc Private Markets Sac Fund Ltd-eqc Biotech Sely Ii Fund` owns 1 companies in total, including SELLAS Life Sciences Group Inc (SLS) .

Click here to see the complete history of Eqc Private Markets Sac Fund Ltd-eqc Biotech Sely Ii Fund`’s form 4 insider trades.

Insider Ownership Summary of Eqc Private Markets Sac Fund Ltd-eqc Biotech Sely Ii Fund`

Ticker	Company	Transaction Date	Type of Owner
SLS	SELLAS Life Sciences Group Inc	2018-09-24	10 percent owner

Eqc Private Markets Sac Fund Ltd-eqc Biotech Sely Ii Fund` Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Eqc Private Markets Sac Fund Ltd-eqc Biotech Sely Ii Fund` Ownership Network

Ownership Network List of Eqc Private Markets Sac Fund Ltd-eqc Biotech Sely Ii Fund`

No Data

Ownership Network Relation of Eqc Private Markets Sac Fund Ltd-eqc Biotech Sely Ii Fund`

Eqc Private Markets Sac Fund Ltd-eqc Biotech Sely Ii Fund` Owned Company Details

What does SELLAS Life Sciences Group Inc do?

Who are the key executives at SELLAS Life Sciences Group Inc?

Eqc Private Markets Sac Fund Ltd-eqc Biotech Sely Ii Fund` is the 10 percent owner of SELLAS Life Sciences Group Inc. Other key executives at SELLAS Life Sciences Group Inc include EVP & Gen. Counsel & Corp. Sec. Barbara A Wood , VP & Finance & Corp Controller John Thomas Burns , and director & President and CEO Angelos M. Stergiou .

SELLAS Life Sciences Group Inc (SLS) Insider Trades Summary

Over the past 18 months, Eqc Private Markets Sac Fund Ltd-eqc Biotech Sely Ii Fund` made no insider transaction in SELLAS Life Sciences Group Inc (SLS). Other recent insider transactions involving SELLAS Life Sciences Group Inc (SLS) include a net purchase of 20,000 shares made by Katherine Bach Kalin , and a net purchase of 20,000 shares made by Jane Wasman .

In summary, during the past 3 months, insiders sold 0 shares of SELLAS Life Sciences Group Inc (SLS) in total and bought 40,000 shares, with a net purchase of 40,000 shares. During the past 18 months, 0 shares of SELLAS Life Sciences Group Inc (SLS) were sold and 40,000 shares were bought by its insiders, resulting in a net purchase of 40,000 shares.

SELLAS Life Sciences Group Inc (SLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

SELLAS Life Sciences Group Inc Insider Transactions

No Available Data

Eqc Private Markets Sac Fund Ltd-eqc Biotech Sely Ii Fund` Mailing Address

Above is the net worth, insider trading, and ownership report for Eqc Private Markets Sac Fund Ltd-eqc Biotech Sely Ii Fund`. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Eqc Private Markets Sac Fund Ltd-eqc Biotech Sely Ii Fund`'s mailing address is: Hamilton D0 Hm08.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.